This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1969 Apr;70(4):817-32.

doi: 10.7326/0003-4819-70-4-817.

NIH clinical staff conference. Burkitt's tumor

P P Carbone, C W Berard, J M Bennett, J L Ziegler, M H Cohen, P Gerber

PMID: 4306129
DOI: 10.7326/0003-4819-70-4-817

NIH clinical staff conference. Burkitt's tumor

P P Carbone et al. Ann Intern Med. 1969 Apr.

. 1969 Apr;70(4):817-32.

doi: 10.7326/0003-4819-70-4-817.

Authors

P P Carbone, C W Berard, J M Bennett, J L Ziegler, M H Cohen, P Gerber

PMID: 4306129
DOI: 10.7326/0003-4819-70-4-817

No abstract available

PubMed Disclaimer

Similar articles

[The EB-virus and its possible connection with infectious mononucleosis and Burkitt's lymphoma].
Rössler R. Rössler R. Internist (Berl). 1970 Oct;11(10):375-6. Internist (Berl). 1970. PMID: 4320245 German. No abstract available.
Viruses associated with Burkitt's tumor.
Bell TM. Bell TM. Prog Med Virol. 1967;9:1-34. Prog Med Virol. 1967. PMID: 4864026 Review. No abstract available.
The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W, Henle G. Henle W, et al. Ann Clin Lab Sci. 1974 Mar-Apr;4(2):109-14. Ann Clin Lab Sci. 1974. PMID: 4362218 Review. No abstract available.
[Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
Nishioka K, Tachibana T, Hirayama T, De Thé G, Klein G. Nishioka K, et al. Nihon Ishikai Zasshi. 1971 Jun 1;65(11):1398-406. Nihon Ishikai Zasshi. 1971. PMID: 4326465 Japanese. No abstract available.
Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: alterations induced by a tumour burden and by BCG administration.
Magrath IT. Magrath IT. Int J Cancer. 1974 Jun 15;13(6):839-49. doi: 10.1002/ijc.2910130611. Int J Cancer. 1974. PMID: 4604572 No abstract available.

See all similar articles

Cited by

Simultaneous double ileoileal intussusception due to Burkitt's lymphoma in a young male.
El Hage Chehade HH, Abtar HK, Seblini MI. El Hage Chehade HH, et al. J Surg Case Rep. 2013 May 9;2013(5):rjt031. doi: 10.1093/jscr/rjt031. J Surg Case Rep. 2013. PMID: 24964440 Free PMC article.
Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.
Mbulaiteye SM, Anderson WF, Bhatia K, Rosenberg PS, Linet MS, Devesa SS. Mbulaiteye SM, et al. Int J Cancer. 2010 Apr 1;126(7):1732-9. doi: 10.1002/ijc.24934. Int J Cancer. 2010. PMID: 19810101 Free PMC article.
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.
Miller G. Miller G. Yale J Biol Med. 1971 Jun;43(6):358-84. Yale J Biol Med. 1971. PMID: 4327067 Free PMC article. Review. No abstract available.
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?
Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, Mbulaiteye SM. Guech-Ongey M, et al. Blood. 2010 Dec 16;116(25):5600-4. doi: 10.1182/blood-2010-03-275917. Epub 2010 Sep 2. Blood. 2010. PMID: 20813897 Free PMC article.
An assessment of massive-dose chemotherapy of malignant disease.
Bergsagel DE. Bergsagel DE. Can Med Assoc J. 1971 Jan 9;104(1):31-6. Can Med Assoc J. 1971. PMID: 4322068 Free PMC article. Review. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.